Dr. Devinsky oversees the development of innovative botanical drugs targeting neurological and mental health disorders. Renowned for his expertise in neurology, autism, epilepsy, and psychiatry, Dr. Devinsky has led groundbreaking research, including the principal investigation for Epidiolex™, the first FDA-approved cannabis drug. His leadership at Ajna BioSciences is instrumental in advancing clinical trials and ensuring the highest standards of safety and efficacy in botanical medicine. Dr. Devinsky's commitment to integrating natural therapies into mainstream healthcare continues to drive significant advancements in the field.